CHROMOGENIC AND FLUORESCENT IN SITU HYBRIDIZATION ANALYSIS OF HER-2/NEU (CERB-B2) EXPRESSION IN FINE NEEDLE ASPIRATION SAMPLES OF BREAST CARCINOMA: A PILOT STUDY COMPARING FISH, CISH AND IMMUNOCYTOCHEMISTRY

被引:0
|
作者
Kapila, K.
Francis, I.
George, S.
Al-Awadhi, S.
Al-Mulla, F.
机构
[1] Kuwait Univ, Fac Med, Dept Pathol, Cytopathol Unit, Kuwait, Kuwait
[2] Mubarak Al Kabeer Hosp, Cytol Lab, Kuwait, Kuwait
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
引用
收藏
页码:499 / 500
页数:2
相关论文
共 50 条
  • [31] Chromogenic in situ hybridization analysis of HER-2/neu status in breast carcinoma:: Application in screening of patients for trastuzumab (Herceptine®) therapy
    Kumamoto, H
    Sasano, H
    Taniguchi, T
    Suzuki, T
    Moriya, T
    Ichinohasama, R
    PATHOLOGY INTERNATIONAL, 2001, 51 (08) : 579 - 584
  • [32] Chromogenic in situ hybridization (CISH) is a reliable method for detecting HER-2 gene status in breast cancer: A multicenter study comparing three methods
    Gong, Y.
    Sweet, W.
    Duh, Y. J.
    Greenfield, L.
    Fang, Y.
    Zhao, J.
    Tarco, E.
    Symmans, W. F.
    Isolo, J.
    Sneige, N.
    LABORATORY INVESTIGATION, 2008, 88 : 33A - 33A
  • [33] Chromogenic in situ hybridization (CISH) is a reliable method for detecting HER-2 gene status in breast cancer: A Multicenter study comparing three methods
    Gong, Y.
    Sweet, W.
    Duh, Y. J.
    Greenfield, L.
    Fang, Y.
    Zhao, J.
    Tarco, E.
    Symmans, W. F.
    Isola, J.
    Sneige, N.
    MODERN PATHOLOGY, 2008, 21 : 33A - 33A
  • [34] Basic examination of HER2 gene in breast carcinoma by chromogenic in situ hybridization:: Application to fine needle aspiration cytology specimens
    Katayama, H.
    Maeda, S.
    Kudo, M.
    Naito, Z.
    ACTA CYTOLOGICA, 2007, 51 (02) : 349 - 349
  • [35] HER-2 NEU in breast cancer patients.: Immunohistochemical comparison with mono and polyclonal antibodies.: Amplification with Chromogenic in Situ Hybridization (CISH)
    Perez, M. I.
    Picon, G.
    Ugalde, J.
    PROCEEDINGS OF THE 3RD INTERCONTINENTAL CONGRESS OF PATHOLOGY - FREE PAPERS, 2008, : 177 - 181
  • [36] Chromogenic in situ hybridization (CISH), a helpful tool for the pathologist to identify HER2/NEU amplification in breast carcinomas.: Comparative study with IHC and FISH
    Ning, EL
    Ronchetti, R
    Torres-Cabala, CA
    Teller, LS
    MODERN PATHOLOGY, 2005, 18 : 40A - 40A
  • [37] Chromogenic in situ hybridization (CISH), a helpful tool for the pathologist to identify HER2/NEU amplification in breast carcinomas. Comparative study with IHC and FISH
    Ning, EMLL
    Ronchetti, R
    Torres-Cabala, CA
    Teller, LS
    Merino, MJ
    LABORATORY INVESTIGATION, 2005, 85 : 40A - 40A
  • [38] HER-2/neu protein expression and gene amplification in breast cancer: immunohistochemistry and chromogenic in situ hybridization study using tissue microarray
    Hazim, Ammar Imad
    Kaur, Gurjeet
    HEALTHMED, 2011, 5 (05): : 1065 - 1071
  • [39] HER-2/neu amplification detected by fluorescence in situ hybridization in fine needle aspirates from primary breast cancer
    Bozzetti, C
    Nizzoli, R
    Guazzi, A
    Flora, M
    Bassano, C
    Crafa, P
    Naldi, N
    Cascinu, S
    ANNALS OF ONCOLOGY, 2002, 13 (09) : 1398 - 1403
  • [40] Comparison of HER-2/NEU amplification using fluorescent in situ hybridization (FISH) with immunohistochemically determined overexpression in breast cancers
    Nelson, DL
    Potts, SA
    Bromley, C
    Pou, B
    Raab, SS
    Thomas, PA
    LABORATORY INVESTIGATION, 1996, 74 (01) : 106 - 106